Stay updated on EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial
Sign up to get notified when there's something new on the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page.

Latest updates to the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page
- Check7 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new version of the ClinicalTrials.gov page. This is an internal update and does not change the study details presented.SummaryDifference0.0%

- Check14 days agoChange DetectedThe page's related topics panel was updated to remove the entries for 'Prostate cancer' and 'MedlinePlus Genetics'.SummaryDifference0.1%

- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedThe page’s sidebar/footer “related topics” entries were updated (including Prostate cancer / MedlinePlus Genetics), and the site/version label changed from Revision: v3.5.2 to v3.5.3.SummaryDifference0.2%

- Check36 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check43 days agoChange DetectedRemoved links to Prostate cancer and MedlinePlus Genetics from the related topics section.SummaryDifference0.1%

- Check50 days agoChange DetectedDifference0.2%

Stay in the know with updates to EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the EPI-7386 Combo in mCRPC vs Enzalutamide Alone Clinical Trial page.